Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
- ByBenzinga-
Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially...